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Background: A total of 30 endophytic fungi (AAP-PS 1–30) were isolated from the medicinal herb Phyllanthus
amarus and screened for the production of Trichothecinol-A. Out of all the endophytic strains screened for
Trichothecinol-A production, the culture filtrate of AAP-PS-1 extracted with ethyl acetate yielded Trichothecinol-A
extracellularly in appreciable amounts. Trichothecinol-A was purified, quantified and completely characterized by
different standard chromatographic and spectroscopic techniques including reverse phase HPLC, 1D and 2D
NMR spectroscopy, etc. The compound was tested for antifungal activity against filamentous fungi and yeast,
apoptotic activity against B16F10 cells, anticancer activity against MDA-MB-231, HeLa and B16F10 cells as well as
antimetastatic activity against MDA-MB-231 cell line.
Results: The endophyte producing Trichothecinol-A was identified as Trichothecium sp. by morphological, cultural
and molecular methods. RP-HPLC analyses performed on a Waters model using a C18 symmetry pack column with
a flow rate of 0.5 ml/min and the eluting compounds were detected by a dual mode wavelength detector set at
220 nm and 240 nm. The 1D (1H, 13C) and 2D NMR (COSY, NOESY, TOCSY, DEPT, 13C–1H HMBC, 13C–1H HSQC),
ESI-MS, HRMS, IR and UV–vis show conclusively that the isolated compound was Trichothecinol–A. One liter of
Trichothecium sp. yielded 4.37 mg of Trichothecinol-A. Trichothecinol-A exhibited antifungal activity against
Cryptococcus albidus (NCIM 3372) up to 20 μg/ml. Cytotoxicity studies indicate that Trichothecinol-A causes 50%
cell death at 500nM concentration in HeLa and B16F10 cells and induces apoptosis in later. Inhibition of wound
migration assay performed on MDA-MB-231 cells reveals that 500nM of Trichothecinol-A was able to inhibit wound
migration by 50% indicating its remarkable antimetastatic property.
Conclusion: The compound Trichothecinol-A has previously been isolated from Trichothecium roseum and
characterized by various standard techniques. Anti-cancer studies conducted on Trichothecinol-A showed that it
significantly inhibits cancer cell migration and can thus be developed as a new class of anti-metastatic drug. Here,
we for the first time report the anti-metastatic as well as anti-fungal activity exhibited by Trichothecinol-A isolated
by us from the endophytic fungus Trichothecium sp. of medicinal plant Phyllanthus amarus. Trichothecinol-A also
exhibited apoptotic activity.
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Endophytic fungi are microorganisms which spend the
whole or part of their life-cycle residing symbiotically
within the healthy tissues of host plants, inter-and/or
intra-cellularly and produce bioactive natural products
or drugs and derivatives; meanwhile causing no damage
or disease to their hosts [1].
Owing to the huge developments in the fields of gen-
etic engineering, microbial fermentation technology, etc.
the past two decades have seen a major increase in the
number of researchers working hard to explore the
endophytic fungal diversity, and better understand the
relationships between endophytic fungi and their host
plants, in an attempt to employ endophytes to obtain
valuable compounds of plant origin without exploiting
plant parts and to improve the productivity of the ones
already being derived by optimizing fermentation condi-
tions to reap benefits of abundant renewable supply
[2,3]. Thus, endophytes hold tremendous promise as an
alternative eco-friendly source for efficiently produ-
cing valuable bioactive compounds in the future with
varied applications in both the research and applied
fields of medicine, food industry, agriculture, pest
management, etc.
Trichothecenes are a vast group of structurally and
chemically related mycotoxins which have a strong im-
pact on the health and well-being of humans, plants
and farm animals. These mycotoxins are complex ses-
quiterpene secondary metabolites produced by fungi
belonging to various species of Fusarium, Trichothe-
cium, Trichoderma, Myrothecium, Cephalosporium, Sta-
chybotrys, etc. These mycotoxins are highly stable even
during the milling, processing and cooking of food
stuffs and thus it’s very difficult to get rid of them [4,5].
It is these trichothecenes which are responsible for the
toxicity and spoilage of grains, fruits, vegetables, tubers
and other vegetative products worldwide.
Trichothecenes are minute, amphiphatic molecules
which are extremely powerful inhibitors of protein syn-
thesis as these have their specific site of action located
on a very crucial site on the ribosomal RNA (rRNA),
thus interfering with the normal polypeptide chain initi-
ation, elongation and termination [6,7]. Altering the bio-
logical activity of trichothecenes has helped in inducing
anti-bacterial, anti-viral, insecticidal, phytotoxic, cytoxic,
anti-biotic and anti-tumour properties in the resultant
molecules [8]. Konishi et al. reported the trichothecinols
A–C, all showing remarkable potential at inhibiting
EBV-EA activation induced by TPA (12-O-tetradeca-
noylphorbol-13-acetate) in Raji cells [9]. Out of these,
the most active compound, Trichothecinol-A also sup-
pressed TPA-induced tumour promotion on mouse skin
initiated with DMBA (7,12-dimethylbenz[a]anthracene)
in a two-stage carcinogenesis experiment.As part of our ongoing research for plant based drugs
using endophytic fungi, we started the isolation and
screening of endophytic fungi from medicinal herb Phyl-
lanthus amarus for the production of various beneficial
bioactive secondary metabolites and identified a fungal
strain Trichothecium sp. which during the present inves-
tigation produced only antifungal secondary metabolites
against Aspergillus niger. The compound was identified
as sesquiterpenoid trichothecene mycotoxin and com-
pletely characterized as Trichothecinol-A. P. amarus was
used as it is a known astringent, deobstruent, stomachic,
diuretic, febrifugal, antiseptic, employed in dropsy and
diseases of urinogenital system; its leaves are expector-
ant, diaphoretic; seeds are carminative, laxative, astrin-
gent to the bowels, tonic to the liver, and used as a
remedy for bronchitis, earache, griping, opthalmia and
ascites [10-13]. Fresh roots and leaves of this plant have
also been reported to be potent remedy for jaundice. All
these features made P. amarus a very worthy candidate
for our study.
The present work focuses on the isolation, purification
and complete characterization of Trichothecinol-A from
the endophytic fungus Trichothecium sp. isolated from
P. amarus. The anti-fungal, anti-cancer (anti-proliferative),
anti-metastatic and apoptotic activities of trichothecinol-A
revealed its class-apart potential to be developed as a drug
for each mentioned field.
Results and discussion
Isolation, purification and identification of endophytic
fungus producing Trichothecinol-A
Total thirty endophytic fungi were isolated from leaves
and stems of P. amarus and only one culture (AAP-
PS-1) isolated from leaves was found to produce
Trichothecinol-A extracellularly. Trichothecinol-A pro-
ducing fungal culture was identified using molecular and
morphological approaches. Morphological observations
revealed that conidiophores were long, slender, simple,
bearing conidia singly, apically, sometimes held together
in groups or chains; conidia were hyaline, 2-celled and
ovoid to ellipsoid.
Amplification of fungal genomic DNA by primers
ITS1 and ITS4 yielded 650 bps fragment (Accession No.
JN603460). The analysis of sequence revealed 99.9%
identity with that of Trichothecium roseum. Phylogenetic
analysis of this strain AAP-PS-1 based on ITS sequences
exhibited 98% nucleotide sequence similarity with Tri-
chothecium roseum, the phylogenetically closest vali-
dated genus (Figure 1). The ITS sequence analysis and
homology alignment of isolate AAP-PS-1 using BLAST
and Clustal-W programme respectively revealed similar-
ity with T. roseum. Also, morphological and cultural
studies confirm that the isolate belongs to genus Tri-
chothecium [14].
Figure 1 Phylogenetic tree highlighting the position of Trichothecium sp. within the closely related genus. GenBank accession numbers
are indicated in parentheses. The scale bar represents a 5% nucleotide sequence divergence.
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of Trichothecinol-A
Purified Trichothecinol-A eluted at retention time of
34 minutes when loaded on analytical C18 symmetry
pack column with a flow rate of 0.5 mL/min. EtoAc
extract of one litre of filterate of Trichothecium sp. fer-
mented in modified S7 medium yielded 4.37 mg of
Trichothecinol-A. Maximum UV absorption was re-
corded at 251 nm in ethyl acetate. The mass spectrum
showed molecular ion at m/z 349.57 and at m/z 371.28
attributing to M +H and M +Na ions of Trichothecinol-
A respectively. The HRMS spectrum showed molecular
ion at 348.0683 attributing to ions of Trichothecinol-A
(C19H24O6). The FTIR spectrum showed characteristic
bands of Trichothecinol-A at 1679, 1721 and 3452 cm−1.
(HPLC details, UV-visible spectroscopy measurements,
FTIR spectroscopy measurements, ESI-MS details are
included as supporting information (Additional file 1:
Figure S1 – S4).
The 1H NMR spectrum of the Trichothecinol-A showed
the presence of 24 protons with the olefinic peaks in side
chain ester linkage at ~6.48δ, 5.89δ and the ring olefinic
proton at ~6.60δ. The methyl groups (Me 14, 15, 16 and
20) appeared at ~0.76δ, ~1.03 δ, ~1.83δ and ~2.17δ, re-
spectively. The protons of epoxide methylene group (13a,
13b) appeared as doublets at ~2.81δ and ~3.08δ. The
other methylene group (7a, 7b) resonated at ~2.33δ and
~2.96δ. The most noticeable feature of the 1H spectrum is
the presence of a broad peak at ~3.48δ which belongs to
OH group proton. 13C NMR spectrum showed the pres-
ence of 19 carbons which included two carbonyls
(198.52δ, 168.05δ), four olefinic (148δ to 119δ) and thir-
teen sp3 carbons in the region 85δ to 5δ. The assignmentsof the 1H and 13C spectra are presented in Table 1 and
Figure 2. The spectral details are included as Supporting
information (Additional file 1: Figures S5-S12, Tables S1
and S2). The NMR spectral features are found to match
very well with the one reported by Konishi et al. [9].
Antifungal activity of Trichothecinol-A
In contrary to earlier reports [9], we for the first time dem-
onstrated antifungal activity of Trichothecinol-A against a
range of filamentous fungi and yeast. Trichothecinol-A
exhibited moderate activity against yeast Cryptococcus
albidus var diffluens NCIM 3372 up to 20 μg/mL. MIC
and IC50 values were determined as described below
(Table 2). Dose response curves of Trichothecinol-A
are included as supporting information (Additional file 1:
Figure S13).
Trichothecinol-A exhibit cytotoxicity at nanomolar
concentrations against B16F10 and HeLa cells and
effectively inhibit cell migration in MDA-MB-231 cells
Cytotoxicity studies indicated that B16F10 and HeLa
cells show enhanced sensitivity to Trichothecinol-A
compared to MDA-MB-231 cells. Trichothecinol-A in-
duced about 50% cell death in HeLa and B16F10 cells
compared to about 25% in MDA-MB-231 cells at 500
nM concentrations (Figure 3).
The effect of Trichothecinol-A on B16F10 cell death
was performed by cell cycle analysis. Briefly, cells were
treated with Trichothecinol-A in a dose of 0–5 μM for 12
and 24 h respectively and then stained with PI (propidium
iodide). The DNA fluorescence histogram of PI-stained
cells revealed a distinct quantifiable region beyond G1
peak (Figure 4).





1 Saccharomyces cerevisiae NCIM 3045 17.16 36
2 Cryptococcus albidus var diffluens
NCIM 3371
4.08 36
3 Cryptococcus albidus var diffluens
NCIM 3372
2.5 20
4 Fusarium oxysporum NCIM 1043 7.16 >100
5 Aspergillus flavus NCIM 535 24.3 >100
6 Trichoderma reesei NCIM 992 15 90
7 Penicillium expansum NCIM 939 6.61 50
8 Trichoderma viride NCIM 1051 36.6 >100
9 Paecilomyces varioti NCIM 1217 8.69 70
10 Aspergillus niger NCIM 773 9.12 >100
$NCIM corresponds to National Collection of Industrial Microorganisms,
Pune, India.
Table 1 1H and 13C NMR assignments* of Trichothecinol-A

















14(CH3) 0.76, s 6.00
15 (CH3) 1.03, s 18.46




20 (CH3) 2.17(1.80,7.30) 15.65
* Numbering of various atoms are given in Figure 2.
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observed in Trichothecinol-A treated cells in a time
dependent manner. 500 nM of Trichothecinol-A had
12.7% sub G0 population as compared to 3.88% in ve-
hicle control in 12 h. However, cells treated with 500
nM of Trichothecinol-A for 24 h resulted in anFigure 2 Selected nOe interactions of Trichothecinol-A (Mw:
348, C19H24O6).increase of apoptotic fraction to 52.96% versus 16.68%
in vehicle control.
Enhanced migratory capacity is one of the hall marks of
highly invasive tumor cells. Inhibition of cancer cell mi-
gration could be an effective means of preventing cancer
metastasis, thereby enabling confinement of primary tu-
mors in manageable form, making surgical options more
viable [15]. During opening phase of the metastatic cas-
cade, cancer cells penetrate into surrounding tissues and
blood vessels and it has been shown to be the rate limiting
step in an experimental model [16]. Therefore, inhibition
of the cell migration represents a potential therapeutic ap-
proach for the treatment of tumor metastasis. Here, we
studied the inhibitory effect of Trichothecinol-A in MDA-
MB-231 cell migration at various concentrations. Percent-
age of wound closure was determined by the difference in
area covered by migrated cells in control versus treated
with Trichothecinol-A at 0 or 18 h. The results show that
the 500 nM of Trichothecinol-A was able to inhibit
wound closure by 50% where as 2.5 and 5 μM concentra-
tions of Trichothecinol-A inhibited migration up to 75%
as compared to vehicle control (Figure 5a & b).
Because, the common approach of chemotherapy is to
decrease the growth rate (cell division) of the cancer cells,
the side effects are seen in bodily systems that naturally
have a rapid turnover of cells including skin, hair, gastro-
intestinal and bone marrow. These healthy, normal cells
also end up damaged by the chemotherapy program.
Hence, it’s reasonable to look out for compounds with
antimetastatic activity which could be further developed
as lead against cancer metastasis. As, Trichothecinol-A is
showing promising antimetastatic activity against human
breast carcinoma (MDA-MBA-231) and antiproliferative
activity against skin carcinoma (B16F10) at nanomolar
concentration, therefore, it can be used as scaffold in drug
Figure 3 Effect of Trichothecinol-A on cancer cell proliferation.
MDA-MB-231, HeLa and B16F10 cells were treated with DMSO as
vehicle control and with Trichothecinol-A at varying concentrations
from 0–100 μM for 24 h and cell viability was determined by MTT assay.
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specificity and favourable pharmacological properties. Fur-
ther efforts are needed to modify the compound to re-
move sites of non specific toxicity and understand the
mechanism by which this compound inhibits cancer cell
growth and migration.
Materials and methods
Isolation, purification, identification and screening of
endophytic fungi for the production of Trichothecinol – A
A total of 30 endophytic fungi (AAP-PS 1–30) were isolated
from medicinal herb P. amarus as described elsewhereFigure 4 Cell Cycle analysis of B16F10 cells by Flow Cytometry: B16 F
Trichothecinol-A at concentrations of 0–5 μM for 12 and 24 h respect
DNA content using flow cytometry.[17-19]. Each fungal culture was checked for purity
and transferred to agar slants by hyphal tip as well as
single spore isolation method [17,20]. Production of
Trichothecinol-A by endophytic fungi was studied by a two
stage fermentation procedure [21]. The flasks containing
MGYP media (Malt extract 0.3%, Glucose 1%, Yeast extract
0.3%, Peptone 0.5%) were inoculated with agar plugs of my-
celium from 7 day old slants. The inoculated flasks were in-
cubated at 28°C on rotary shaker at 180 rpm for 6 days.
These cultures were used as seed culture (first stage). For
Trichothecinol –A production, 20 mL seed culture was
transferred to 500 mL Erlenmeyer flask containing modi-
fied S7 medium [21]. The flasks were incubated at 28°C for
30 days as stationary culture (second stage). After incuba-
tion, the cultures were harvested and passed through sterile
cotton to separate mycelial mat from culture filtrate. The
culture filtrate was lyophilized and extracted thrice with
equal volumes of ethyl acetate. The extracts were pooled
and dried with anhydrous sodium sulphate and concen-
trated at 40°C under reduced pressure to yield crude ex-
tract. The antifungal activity and a method developed by
Sorenson et. al. was used to detect Trichothecinol-A in
crude extract [22]. The culture (AAP-PS-1) producing
Trichothecinol-A was used for further studies.
Identification of endophytic fungus producing
Trichothecinol-A by morphological and molecular
methods
Identity of endophytic fungal culture (AAP-PS-1) produ-
cing Trichothecinol-A was established by using morpho-
logical and molecular approaches. For studying the
morphological features, the fungus was grown on potato
dextrose agar (potato 25%, dextrose 2%, agar 2%).10 cells were treated with DMSO as vehicle control or with
ively and cell cycle distribution was determined by measuring
Figure 5 Inhibition of cell migration by Trichothecinol-A: a. MDA-MB-231 cells were treated with DMSO as vehicle and Trichothecinol-A
at concentrations of 0–5 μm for 18 h and photographs were taken. b. The areas of migrated cells were quantified and represented as bar
graph. *p = .0013, **p = .0003 vs. vehicle control.
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conidiophores and conidia were microscopically studied
(Carl Ziess Axiovert 25 Inverted microscope and Nikon
Eclipse E200). The genomic DNA was isolated by salting
out method with little modification [23]. Sonication for
a period of 5 min was done before lysozyme treatment.
ITS region of genomic DNA was amplified using ITS1
TCCGTAGGTGAACCTGCGG (forward) and ITS4
TCCTCCGCTTATTGATATGC (reverse) primers. PCR
products were eluted from agarose gel by protocoldescribed in Axygen™ gel elution kit, Biosciences USA.
The purified PCR product was ligated with pGEM-T
vector and transformed into competent E.coli XL-1 cells
[24]. Plasmid containing the insert was isolated using al-
kaline lysis method [24]. The cloned fragments were se-
quenced using Sangers dideoxy method using ABI prism
big dye terminator cycle sequencing kit from ABI system
[25]. The sequence obtained was further analysed for its
homology by using online tool nucleotide BLAST. The
multiple sequence alignments were carried out using
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using the maximum-likelihood method within MEGA
program. The bootstrap of consensus tree was inferred
from 500 replicates. The evolutionary distances were
computed using the Kimura2 parameter. All positions
containing gaps and missing data were eliminated from
the dataset (Complete deletion option). Acremonium
strictum were used as an out-group.
Purification and quantification of Trichothecinol-A
Trichothecinol-A was purified using preperative TLC
and RP-HPLC. TLC plates coated with 0.5 mm thickness
of silica were used for preparative TLC. Approximately
0.5 mL of crude sample dissolved in methanol was
loaded on to plate and developed in hexane: ethyl acet-
ate (2:1) solvent system. The developed plates were air
dried and exposed to iodine vapours. Individual bands
were scrapped, eluted with ethyl acetate, concentrated in
vacuo and tested for antifungal activity against Aspergil-
lus niger by agar well diffusion method. Out of eight
bands, second and fifth band showed good antifungal
activity. The second band was further processed for
purification by analytical RP HPLC. HPLC analysis was
performed on a Waters model using a C18 symmetry
pack column with the flow rate of 0.5 mL/min and
eluted with a 40 minutes gradient of water: actonitrile
(95: 5). The Trichothecinol-A was detected by a dual
mode wavelength detector set at 220 nm and 240 nm.
Quantification of Trichothecinol-A by HPLC
Stock solution of different concentrations (1 mg/ml,
3 mg/ml, 5 mg/ml and 10 mg/ml) of a purified
Trichothecinol-A was prepared in HPLC grade aceto-
nitrile. 10 μl of each stock solution was injected in
HPLC to generate a standard graph of peak area v/s con-
centration. Then, the known volume of (10 μl) crude
dissolved in HPLC grade acetonitrile containing un-
known concentration of Trichothecinol-A was analysed
by HPLC and the peak area of Trichothecinol-A con-
taining peak was compared to standard graph to calcu-
late its concentration.
Complete characterization of Trichothecinol-A
UV-visible spectroscopy measurements were carried out
on Jasco dual beam spectrophotometer (model V- 570)
operated at resolution of 1 nm. Molecular mass of the
compound was determined by M/S Applied Biosystems
API QSTAR pulsar (ESI-MS) mass spectrometer. HRMS
analysis was carried out using mass spectrometry instru-
ment (model – Autoconcept) by direct injection probe
with resolving power of 6000. FTIR spectroscopy mea-
surements of purified compound taken in Kbr pellet were
carried out using a Perkin-Elmer spectrum one instru-
ment. Spectrometer was used in the diffuse reflectancemode of resolution 2 cm−1. All the NMR measurements
were carried out on Bruker AV 500 spectrometer operat-
ing at 500 MHz and 125 MHz, respectively for 1H and
13C. ~10 mg of the compound was dissolved in CDCl3 in
a 5 mm NMR tube and the 1H, 13C, COSY, NOESY,
TOCSY, 13C–1H HSQC and 13C–1H HMBC experiments
were performed under standard conditions using a 5 mm
BBFO probe at ambient temperature (~ 25°C). Chemical
shifts in the 1H spectra were referenced to residual CHCl3
peak (7.26 ppm), while 13C spectra were referenced to
CDCl3 (77.0 ppm).
Antifungal assay
The purified compound was analyzed for antifungal ac-
tivity against different plant pathogenic, saprophytic
fungi and yeast. Antifungal assay was performed in mi-
crotiter plates as reported earlier [26,27]. Fungal spores
were removed from a 4 days old culture, transferred to
YM broth (Glucose 1%, Malt extract 0.3%, Yeast extract
0.3%) and adjusted to 2x105 spores or cells/mL. The
compound was diluted in DMSO to get desired concen-
trations. 50 μL aliquots of spores were mixed with differ-
ent concentrations of compounds (10 to 100 μg/mL in
10 μL of DMSO). Final volume was adjusted by adding
140 μL YM media. Total assay volume was 200 μL. The
plates were incubated at 28°C for 48 h.
OD 600 measurements
The OD 600 measurements were carried out on microti-
ter plate reader (Bio-Rad xMark). The MIC was deter-
mined as the lowest concentration of Trichothecinol-A
that completely inhibits visible growth of the micro-
organism. The dose response curves were obtained by
plotting concentration of compound v/s% growth inhib-
ition. The IC50 values were determined as the concentra-
tion of Trichothecinol-A that could show 50% of
maximum inhibition.
Cell culture and reagents
Human breast adenocarcinoma (MDA-MB-231), hu-
man cervical cancer (HeLa) and murine melanoma
(B16F10) cell lines were obtained from American Type
Culture Collection and were grown in L-15, DMEM
and RPMI media respectively, supplemented with 10%
fetal bovine serum and 100 U/mL Penicillin and
Streptomycin (Invitrogen). All cells were grown in hu-
midified atmosphere with or without 5% CO2 and 95%
air at 37°C. Tetrazolium dye and Propidium Iodide was
purchased from Sigma.
Cell viability assay
MDA-MB-231, HeLa and B16F10 cells (2x104) were
seeded in 96 well plates. Cells were treated with
Trichothecinol-A for 24 h with indicated concentration.
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MTT [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazo-
lium bromide] (0.5 mg/ml) was added. After 4 h, crystals
were dissolved in isopropanol and A570 was recorded.Flow cytometry analysis
Flow cytometry experiments were performed as de-
scribed earlier [28]. Murine melanoma B16F10 cells were
treated with indicated concentrations of Trichothecinol-
A in RPMI media supplemented with 10% fetal bovine
sera for 12 and 24 h. DNA analysis was done and cell
undergoing apoptosis were determined following propi-
dium iodide staining (FACS Calibar, Becton Dickinson).Wound assay
Wound assay was performed with post confluent MDA-
MB-231 cells as described [29]. Briefly, uniform sized
wounds were made. MDA-MB-231 cells were treated
with 2.5 μM of Trichothecinol-A. DMSO was used as
vehicle control. After 18 h, photographs were taken and
the area of migrated cells was quantified using Image
Pro Plus 6.0 software (Nikon).Statistical analysis
The data reported in cytotoxicity and cell migration exper-
iments are expressed as mean ± S.E. Statistical differences
were determined by Student’s t test. The p value < 0.05
was considered significant.Conclusion
We for the first time have isolated a sesquiterpene viz.
Trichothecinol-A produced by an endophytic fungus Tri-
chothecium sp. isolated from medicinal herb Phyllanthus
amarus. The compound was purified and characterized by
using different chromatographic and spectroscopic tech-
niques. Being non proteinaceous in nature, this compound
holds the promise of potent antiproliferative and most im-
portantly antimetastic lead, if suitably modified by
employing combinatorial chemistry approaches to en-
hance its drug like properties. Trichothecinol-A exhibits
appreciable antimetastatic activity against human breast
carcinoma (MDA-MBA-231) and antiproliferative activity
against skin carcinoma (B16F10) at nanomolar concentra-
tions. Also, Trichothecinol-A showed good antifungal ac-
tivity against Cryptococcus albidus var diffluens (NCIM
3371 and 3372) and Penicillium expansum (NCIM 939).
Therefore, the above compound could be used as scaffold
in drug discovery programmes to synthesize effective and
more specific analogues which can be further developed
as drugs. Further studies are required to understand the
mechanism by which this compound inhibit cancer cell
growth and metastasis.Additional file
Additional file 1: Figure S1. HPLC was carried out using waters
separation module. Figure S2: UV-visible spectroscopy measurements were
carried out on Perkin Elmer spectrophotometer (model lambda - 750)
operated at resolution of 1nm. Maximum Uv absorption was observed at
251nm in ethyl acetate. Figure S3: FTIR spectroscopy measurements of
purified compound taken in Kbr pellet were carried out using a Perkin-
Elmer spectrum one instrument. Figure S4: Molecular mass of the
compound was determined by M/S Applied Biosystems API QSTAR pulsar
(ESI-MS) mass spectrometer. Figure S5: 500 MHz 1H NMR spectrum of
Trichothecinol –A in CDCl3. Figure S6: 125 MHz
13C NMR spectrum of
Trichothecinol -A in CDCl3. Figure S7: DEPT 135 spectrum of Trichothecinol
-A, where the CH2 carbons appear with a negative phase. Figure S8: 500
MHz COSY spectrum of Trichothecinol –A in 99.8%
deuterated CDCl3. The cross peaks indicates scalar couplings. Figure S9:
500 MHz NOESY spectrum of the Trichothecinol-A in 99.8% deuterated
CDCl3 A mixing time of 1 second was employed for the measurement.
Figure S10: 500 MHz TOCSY correlations of the Trichothecinol-A in CDCl3.
Figure S11: 1H-13C HSQC spectrum of the Trichothecinol-A with the 1H
and 13C DEPT spectra shown as projections in the F2 and F1 dimensions,
respectively. Figure S12: 1H-13C HMBC correlations of the Trichothecinol-A.
Figure S13: Dose response curves of Trichothecinol-A. Table S1: Homo
nuclear correlations observed in Trichothecinol-A. Table S2: Major 1H-13C
correlations observed in Trichothecinol-A.
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